查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828055

2025年女性生育力與快速妊娠檢測全球市場報告

Female Fertility And Pregnancy Rapid Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，女性生育和快速妊娠測試市場規模強勁成長，從2024年的14億美元增加到2025年的14.8億美元，複合年成長率為5.2%。預測期內的成長可歸因於生殖健康意識的增強、生育延遲、文化和社會變革、母親年齡成長以及商店供應的增加。

預計未來幾年女性生育和快速妊娠檢測市場規模將強勁成長，到2029年將達到19.3億美元，複合年成長率為7.0%。預測期內的成長可歸因於個人化醫療方法、人們對自然計劃生育日益成長的興趣、全球不孕症治療旅遊、政府計劃生育舉措以及對平價醫療的努力。預測期內的主要趨勢包括數位健康整合、遠端醫療的普及、醫療保健產業的夥伴夥伴關係與合作、檢測套組的線上零售管道以及排卵預測測試的創新。

快速女性生育力和懷孕測試是一種檢測女性生育力和懷孕情況的方法，可以使用藥局出售的尿液檢查或在醫生檢查室進行的血液測試。這些快速檢測套組提供了一種簡單易用的不孕症檢測解決方案，旨在檢測女性排卵並診斷不孕症。

我們主要的女性生育力和懷孕快速檢測套組產品包括不孕不育快速檢測套組和懷孕快速檢測套組。生育力快速檢測試劑盒是一種體外診斷工具，旨在在幾分鐘內定性地識別和評估懷孕、可孕週期、排卵和精子數量。這些設備有多種規格，包括電子指示儀和線指示儀，可用於 FSH尿液檢查檢查、LH尿液檢查檢查、HCG 血液檢測和 HCG尿液檢查檢查等檢測。這些套件可透過各種分銷管道購買，包括醫院、零售店和線上平台。

2025年春季，美國關稅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

女性生育和妊娠快速檢測市場研究報告是商業研究公司 (The Business Research Company) 最新報告系列之一，提供女性生育和妊娠快速檢測市場統計數據，例如全球市場規模、區域佔有率、競爭對手在女性生育和妊娠快速檢測市場的佔有率、詳細的女性生育和妊娠快速檢測細分市場、市場趨勢以及女性生育和妊娠快速檢測行業的商機。這份女性生育和妊娠快速檢測市場研究報告對該行業的現狀和未來情況進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長7.0%，較先前預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，導致來自印度和丹麥等主要地區的單株抗體試紙和側流膜材料供應鏈中斷，從而導致家用檢測服務減少，生殖健康產品價格上漲。此外，由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

婦科疾病盛行率的上升預計將推動女性生育和快速妊娠檢測市場的成長。婦科疾病影響女性生殖系統，包括影響子宮、卵巢、陰道和其他相關器官的各種疾病。透過測試診斷與不孕症相關的問題可以解決不孕症問題並減輕婦科疾病的影響。根據美國國家醫學圖書館 2022 年 7 月的報告，常見的婦科疾病包括子宮肌瘤、自然流產、卵巢功能障礙、卵巢異位症、多囊性卵巢症候群和月經。因此，由於此類疾病的發生率不斷上升，女性生育和快速懷孕檢測市場正在經歷成長。

預計未來幾年，不斷成長的醫療保健支出將推動女性生育和快速妊娠檢測市場的成長。醫療保健支出是指在特定時期內分配給醫療保健產品和服務的總財政資源，通常是在國家或機構層級。醫療保健投資的增加刺激了生殖健康的研發，從而帶來技術進步、改善檢測管道以及更全面的生殖保健方法，使個人和醫療保健系統都受益。例如，根據美國機構醫療保險和醫療補助服務中心發布的 2021-2030 年國家衛生支出 (NHE) 報告，預計 2021 年至 2030 年期間國家醫療保健支出將以年均 5.1% 的速度成長，達到約 6.8 兆美元。此外，醫療保險支出預計將以年均 7.2% 的速度成長，而醫療補助支出預計在此期間將以年均 5.6% 的速度成長。因此，醫療保健支出的增加正在推動女性生育和快速妊娠測試市場的擴張。

女性生育和快速妊娠檢測市場的一個共同趨勢是產品創新，尤其是創新檢測套組的開發。主要企業正專注於創造新穎的解決方案，以提升其市場佔有率。例如，總部位於以色列的研發公司 Salignostics 於 2022 年 11 月推出了基於唾液的懷孕檢測 Salistick。 Salistick 是一種開創性的基於唾液的快速妊娠檢測，它透過識別唾液中存在的妊娠激素 (HCG) 來檢測早期妊娠，具有改進的使用者介面和高準確度。該套件的技術允許使用者收集唾液進行測試並在 10 分鐘內獲得結果，透過創新方法提供便利和快速的懷孕檢測。

女性生育和快速妊娠檢測市場的主要企業正專注於創新產品，例如家用生育檢測套組，旨在讓人們舒適地在家中評估生育狀況。家用生育檢測套組是一種設備或套件，旨在讓人們無需去診所即可自行採集樣本並分析荷爾蒙水平和生殖健康指標。例如，2022 年 1 月，總部位於紐約的生育診所和家庭建設福利提供者網路 Kind Body 推出了 Kind at Home 生育測試。此檢測套組可全面評估性和生育狀況，只需在家中刺破手指即可進行。結果可在幾天內獲得，並可透過專有的 Kind Body 平台存取。

2022年5月，總部位於英國的女性健康公司Hertility收購了Grip，收購金額未揭露。此次收購旨在拓展Hertility的荷爾蒙檢測能力，並增強其生殖健康服務，從而實現更準確的評估，並改善不孕症治療的患者預後。 Grip總部位於荷蘭，專注於荷爾蒙分析和生殖健康的創新解決方案。

女性生育力和快速妊娠檢測市場涵蓋套件檢測女性妊娠和不孕症的尿液檢查和血液檢測套組的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球女性生育能力和快速妊娠測試：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球女性生育與妊娠快速檢測市場：成長率分析
  • 全球女性生育與妊娠快速檢測市場表現：規模與成長，2019-2024
  • 全球女性生育與懷孕快速檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球女性生育力和快速妊娠測試：總目標市場（TAM）

第6章 市場細分

  • 全球女性生育力和妊娠快速檢測市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 不孕不育快速檢測套組
  • 快速妊娠檢測套組
  • 全球女性生育力和妊娠快速檢測市場（按設備類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 數位裝置
  • 線路指示器
  • 全球女性生育力和妊娠快速檢測市場（按檢測類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • FSH尿液檢查
  • 尿液促黃尿液檢查
  • hCG 血液測試
  • hCG尿液檢查
  • 全球女性生育力及懷孕快速檢測市場（依通路、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院頻道
  • 零售通路
  • 線上通路
  • 全球女性生育力與懷孕快速檢測市場：生育力快速檢測套組細分市場、類型、效能及預測（2019-2024 年、2024-2029 年、2034 年）
  • 排卵預測套件
  • 黃體激素（LH）檢測套組
  • 濾泡刺激素（FSH）檢測套組
  • 全球女性生育力與妊娠快速檢測市場：快速妊娠檢測套組細分、類型、性能及預測（2019-2024、2024-2029、2034）
  • 尿液檢查妊娠試驗
  • 血液妊娠試驗
  • 妊娠及不孕症綜合檢測

第7章 區域和國家分析

  • 全球女性生育力和懷孕快速檢測市場（按地區、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 全球女性生育力與懷孕快速檢測市場：國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 女性生育與快速妊娠測試市場：競爭格局
  • 女性生育與妊娠快速檢測市場：公司簡介
    • Abbott Laboratories
    • Atlas Medical GmbH
    • bioMerieux SA
    • Church & Dwight Co. Inc.
    • Quidel Corporation

第31章：其他領先和創新企業

  • Egens Group
  • Eurofins Scientific SE
  • Everlywell Inc.
  • Genea Pty Limited
  • Geratherm Medical AG
  • SA Scientific Ltd.
  • Artron Laboratories Inc.
  • PRIMA Lab SA
  • The Procter & Gamble Company
  • Alere Inc.
  • Prestige Brands Holdings Inc.
  • SPD Swiss Precision Diagnostics GmbH
  • Fairhaven Health LLC
  • Fertility Focus Limited
  • HiLin Life Products Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年女性生育力與快速懷孕檢測市場：提供新機會的國家
  • 2029年女性生育力與快速妊娠檢測市場：細分市場帶來新機會
  • 2029年女性生育力與快速妊娠檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r23357u

The female fertility and pregnancy rapid tests involve methods for testing fertility and pregnancy in women, utilizing drugstore-bought urine tests and blood tests conducted at a doctor's office. These rapid test kits offer a straightforward and user-friendly solution for fertility testing, aiming to detect ovulation and diagnose infertility in females.

The primary products in the female fertility and pregnancy rapid tests category include fertility rapid test kits and pregnancy rapid test kits. Fertility rapid tests are in vitro diagnostic tools designed for the qualitative identification and assessment of pregnancy, fertility cycles, ovulation, and sperm counts within minutes. These devices come in various forms, including digital devices and line-indicator devices, and can be utilized for tests such as FSH urine test, LH urine test, HCG blood testing, and HCG urine testing. These kits are available through different distribution channels, including hospitals, retail outlets, and online platforms.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The female fertility and pregnancy rapid test market research report are one of a series of new reports from The Business Research Company that provides female fertility and pregnancy rapid test market statistics, including female fertility and pregnancy rapid test industry global market size, regional shares, competitors with a female fertility and pregnancy rapid test market share, detailed female fertility and pregnancy rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the female fertility and pregnancy rapid test industry. This female fertility and pregnancy rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The female fertility and pregnancy rapid test market size has grown strongly in recent years. It will grow from $1.4 billion in 2024 to $1.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to increased awareness of reproductive health, delay in childbearing age, cultural and societal changes, rising maternal age, over-the-counter availability.

The female fertility and pregnancy rapid test market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine approaches, rising interest in natural family planning, global fertility tourism, government initiatives for family planning, affordable healthcare initiatives. Major trends in the forecast period include digital health integration, telemedicine adoption, partnerships and collaborations in the healthcare industry, online retail channels for test kit sales, innovations in ovulation prediction tests.

The forecast of 7.0% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for monoclonal antibody strips and lateral flow membrane materials, sourced from key regions such as India and Denmark, which could lead to reduced at-home testing availability and higher prices for reproductive health products.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of gynecological disorders is anticipated to drive growth in the female fertility and pregnancy rapid test market. Gynecological disorders affect the female reproductive system and can include various conditions impacting the uterus, ovaries, vagina, and other related organs. Diagnosing fertility-related issues through tests can address infertility problems, reducing the impact of gynecological disorders. According to a July 2022 report by the National Library of Medicine, prevalent gynecological disorders encompass ailments such as uterine fibroids, spontaneous abortion, ovarian dysfunction, endometriosis, polycystic ovary syndrome, and dysmenorrhea. Hence, the market for female fertility and pregnancy rapid tests is experiencing growth due to the increasing occurrence of such disorders.

The rising healthcare expenditure is projected to fuel the growth of the female fertility and pregnancy rapid test market in the coming years. Healthcare expenditure refers to the total financial resources allocated for healthcare goods and services over a specific period, usually at a national or institutional level. Increased investment in healthcare can bolster research and development in reproductive health, leading to advancements in technology, enhanced accessibility to testing, and a more holistic approach to reproductive care, benefiting both individuals and healthcare systems. For example, according to the 2021-2030 National Health Expenditure (NHE) report released by the Centers for Medicare & Medicaid Services, a US-based federal agency, national health spending is expected to grow by an average of 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. Additionally, Medicare spending is anticipated to increase at an annual rate of 7.2%, while Medicaid spending is projected to grow by 5.6% per year during this period. As a result, the rising healthcare expenditure is driving the expansion of the female fertility and pregnancy rapid test market.

A prevailing trend in the female fertility and pregnancy rapid test market is product innovation, particularly in the development of innovative test kits. Leading companies are focusing on creating novel solutions to fortify their market presence. For instance, in November 2022, Salignostics, an Israel-based research and development firm, introduced Salistick, a saliva-based pregnancy test. Salistick is a pioneering rapid saliva-based pregnancy test that offers improved user interface and high accuracy in detecting early pregnancy by identifying the pregnancy hormone (HCG) in saliva. The kit's technology allows users to collect saliva for testing, providing results in less than 10 minutes, offering convenience and quick detection of pregnancy using an innovative approach.

Major enterprises within the female fertility and pregnancy rapid test market are concentrating on innovative offerings, such as home fertility test kits, aimed at providing enhanced fertility status assessments within the comfort of one's home. A home fertility test kit refers to a device or kit designed for individuals to self-collect samples and analyze hormone levels or reproductive health indicators without visiting a medical facility. For example, in January 2022, Kindbody, a New York-based provider of fertility clinic networks and family-building benefits, introduced the Kind at Home fertility test. This test kit offers a comprehensive assessment of fertility status for both men and women, obtained conveniently from home through a straightforward finger prick. Within a few days, users receive their results and tailored recommendations accessible via the proprietary Kindbody patient platform.

In May 2022, Hertility, a UK-based women's health company, acquired Grip for an undisclosed sum. This acquisition aims to expand Hertility's hormone testing capabilities and strengthen its reproductive health services, allowing for more precise assessments and improved patient outcomes in fertility management. Grip, a Netherlands-based company, specializes in innovative solutions for hormone analysis and reproductive health.

Major companies operating in the female fertility and pregnancy rapid test market include Abbott Laboratories, Atlas Medical GmbH, bioMerieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific SE, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, The Procter & Gamble Company, Alere Inc., Prestige Brands Holdings Inc., SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, HiLin Life Products Inc., Inverness Medical Innovations Inc., UEBE Medical GmbH, Wondfo Biotech Co. Ltd.

North America was the largest region in the female fertility and pregnancy rapid test market in 2024. The regions covered in the female fertility and pregnancy rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the female fertility and pregnancy rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The female fertility and pregnancy rapid test market consists of sales of urine and blood test kits used to detect female pregnancy and fertility. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Female Fertility And Pregnancy Rapid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on female fertility and pregnancy rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for female fertility and pregnancy rapid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The female fertility and pregnancy rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Fertility Rapid Test Kits; Pregnancy Rapid Test Kits
  • 2) By Device Type: Digital Devices; Line-indicator Devices
  • 3) By Test Type: FSH Urine Test; LH Urine Test; hCG Blood Test; hCG Urine Test
  • 4) By Distribution Channel: Hospital Channel; Retail Channel; Online Channel
  • Subsegments:
  • 1) By Fertility Rapid Test Kits: Ovulation Predictor Kits; Luteinizing Hormone (LH) Test Kits; Follicle-Stimulating Hormone (FSH) Test Kits
  • 2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests; Blood-Based Pregnancy Tests; Combo Fertility And Pregnancy Tests
  • Companies Mentioned: Abbott Laboratories; Atlas Medical GmbH; bioMerieux SA; Church & Dwight Co. Inc.; Quidel Corporation; Egens Group; Eurofins Scientific SE; Everlywell Inc.; Genea Pty Limited; Geratherm Medical AG; SA Scientific Ltd.; Artron Laboratories Inc.; PRIMA Lab SA; The Procter & Gamble Company; Alere Inc.; Prestige Brands Holdings Inc.; SPD Swiss Precision Diagnostics GmbH; Fairhaven Health LLC; Fertility Focus Limited; HiLin Life Products Inc.; Inverness Medical Innovations Inc.; UEBE Medical GmbH; Wondfo Biotech Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Female Fertility And Pregnancy Rapid Test Market Characteristics

3. Female Fertility And Pregnancy Rapid Test Market Trends And Strategies

4. Female Fertility And Pregnancy Rapid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Female Fertility And Pregnancy Rapid Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Female Fertility And Pregnancy Rapid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Female Fertility And Pregnancy Rapid Test Market Growth Rate Analysis
  • 5.4. Global Female Fertility And Pregnancy Rapid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Female Fertility And Pregnancy Rapid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Female Fertility And Pregnancy Rapid Test Total Addressable Market (TAM)

6. Female Fertility And Pregnancy Rapid Test Market Segmentation

  • 6.1. Global Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fertility Rapid Test KitS
  • Pregnancy Rapid Test Kits
  • 6.2. Global Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Digital Devices
  • Line-indicator Devices
  • 6.3. Global Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • FSH Urine Test
  • LH Urine Test
  • hCG Blood Test
  • hCG Urine Test
  • 6.4. Global Female Fertility And Pregnancy Rapid Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Channel
  • Retail Channel
  • Online Channel
  • 6.5. Global Female Fertility And Pregnancy Rapid Test Market, Sub-Segmentation Of Fertility Rapid Test Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ovulation Predictor Kits
  • Luteinizing Hormone (LH) Test Kits
  • Follicle-Stimulating Hormone (FSH) Test Kits
  • 6.6. Global Female Fertility And Pregnancy Rapid Test Market, Sub-Segmentation Of Pregnancy Rapid Test Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine-Based Pregnancy Tests
  • Blood-Based Pregnancy Tests
  • Combo Fertility And Pregnancy Tests

7. Female Fertility And Pregnancy Rapid Test Market Regional And Country Analysis

  • 7.1. Global Female Fertility And Pregnancy Rapid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Female Fertility And Pregnancy Rapid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market

  • 8.1. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Female Fertility And Pregnancy Rapid Test Market

  • 9.1. China Female Fertility And Pregnancy Rapid Test Market Overview
  • 9.2. China Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Female Fertility And Pregnancy Rapid Test Market

  • 10.1. India Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Female Fertility And Pregnancy Rapid Test Market

  • 11.1. Japan Female Fertility And Pregnancy Rapid Test Market Overview
  • 11.2. Japan Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Female Fertility And Pregnancy Rapid Test Market

  • 12.1. Australia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Female Fertility And Pregnancy Rapid Test Market

  • 13.1. Indonesia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Female Fertility And Pregnancy Rapid Test Market

  • 14.1. South Korea Female Fertility And Pregnancy Rapid Test Market Overview
  • 14.2. South Korea Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Female Fertility And Pregnancy Rapid Test Market

  • 15.1. Western Europe Female Fertility And Pregnancy Rapid Test Market Overview
  • 15.2. Western Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Female Fertility And Pregnancy Rapid Test Market

  • 16.1. UK Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Female Fertility And Pregnancy Rapid Test Market

  • 17.1. Germany Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Female Fertility And Pregnancy Rapid Test Market

  • 18.1. France Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Female Fertility And Pregnancy Rapid Test Market

  • 19.1. Italy Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Female Fertility And Pregnancy Rapid Test Market

  • 20.1. Spain Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Female Fertility And Pregnancy Rapid Test Market

  • 21.1. Eastern Europe Female Fertility And Pregnancy Rapid Test Market Overview
  • 21.2. Eastern Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Female Fertility And Pregnancy Rapid Test Market

  • 22.1. Russia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Female Fertility And Pregnancy Rapid Test Market

  • 23.1. North America Female Fertility And Pregnancy Rapid Test Market Overview
  • 23.2. North America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Female Fertility And Pregnancy Rapid Test Market

  • 24.1. USA Female Fertility And Pregnancy Rapid Test Market Overview
  • 24.2. USA Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Female Fertility And Pregnancy Rapid Test Market

  • 25.1. Canada Female Fertility And Pregnancy Rapid Test Market Overview
  • 25.2. Canada Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Female Fertility And Pregnancy Rapid Test Market

  • 26.1. South America Female Fertility And Pregnancy Rapid Test Market Overview
  • 26.2. South America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Female Fertility And Pregnancy Rapid Test Market

  • 27.1. Brazil Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Female Fertility And Pregnancy Rapid Test Market

  • 28.1. Middle East Female Fertility And Pregnancy Rapid Test Market Overview
  • 28.2. Middle East Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Female Fertility And Pregnancy Rapid Test Market

  • 29.1. Africa Female Fertility And Pregnancy Rapid Test Market Overview
  • 29.2. Africa Female Fertility And Pregnancy Rapid Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Female Fertility And Pregnancy Rapid Test Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Female Fertility And Pregnancy Rapid Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Female Fertility And Pregnancy Rapid Test Market Competitive Landscape And Company Profiles

  • 30.1. Female Fertility And Pregnancy Rapid Test Market Competitive Landscape
  • 30.2. Female Fertility And Pregnancy Rapid Test Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Atlas Medical GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Church & Dwight Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Female Fertility And Pregnancy Rapid Test Market Other Major And Innovative Companies

  • 31.1. Egens Group
  • 31.2. Eurofins Scientific SE
  • 31.3. Everlywell Inc.
  • 31.4. Genea Pty Limited
  • 31.5. Geratherm Medical AG
  • 31.6. SA Scientific Ltd.
  • 31.7. Artron Laboratories Inc.
  • 31.8. PRIMA Lab SA
  • 31.9. The Procter & Gamble Company
  • 31.10. Alere Inc.
  • 31.11. Prestige Brands Holdings Inc.
  • 31.12. SPD Swiss Precision Diagnostics GmbH
  • 31.13. Fairhaven Health LLC
  • 31.14. Fertility Focus Limited
  • 31.15. HiLin Life Products Inc.

32. Global Female Fertility And Pregnancy Rapid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Female Fertility And Pregnancy Rapid Test Market

34. Recent Developments In The Female Fertility And Pregnancy Rapid Test Market

35. Female Fertility And Pregnancy Rapid Test Market High Potential Countries, Segments and Strategies

  • 35.1 Female Fertility And Pregnancy Rapid Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Female Fertility And Pregnancy Rapid Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Female Fertility And Pregnancy Rapid Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer